ALT, Altimmune, Inc

"Loading Stock Price & Valuation Data ..."

Agentic AI (Pro) Picks for ALT

Subscribe to iPick.ai (Pro) to use Power Picks, Hidden-Gem Picks, and more.


News Summary: Subscribe

Unlock News Summary by Subscribing to iPick.ai Premium!





Unlock Ask ALT by Subscribing to iPick.ai Premium!



Stock Chart




Latest YouTube Video:



CEO:Mr. Jerome Benedict Durso

Headquarter: 910 Clopper Road, Suite 201S, Gaithersburg, MD, United States, 20878

Industry: Biotechnology,   Investment Track: -,   Employees: 57

Business Summary

Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.